about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
2.61
0.01
(0.38%)
38,480.7
XNAS Volume
XNAS 17 Jul, 2026 10:17 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..